Quinolizinone compound, processes for preparation thereof and pharmaceutical composition comprising the same
申请人:FUJISAWA PHARMACEUTICAL CO., LTD.
公开号:EP0157346B1
公开(公告)日:1990-01-31
NOVEL OXOQUINOLIZINE COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF BACTERIAL INFECTION
申请人:F. Hoffmann-La Roche AG
公开号:EP3802549A1
公开(公告)日:2021-04-14
US4650804A
申请人:——
公开号:US4650804A
公开(公告)日:1987-03-17
US4698349A
申请人:——
公开号:US4698349A
公开(公告)日:1987-10-06
[EN] NOVEL OXOQUINOLIZINE COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF BACTERIAL INFECTION<br/>[FR] NOUVEAUX COMPOSÉS D'OXOQUINOLIZINE POUR LE TRAITEMENT ET LA PROPHYLAXIE D'UNE INFECTION BACTÉRIENNE
申请人:HOFFMANN LA ROCHE
公开号:WO2019228940A1
公开(公告)日:2019-12-05
The present invention relates to novel compounds of formula (I), wherein R1 , R2, R3, R4, R5, R6 and R7 are as described herein, and their pharmaceutically 5 acceptable salt, enantiomer or diastereomer thereof, and compositions including the compounds and methods of using the compounds.